Buena-Atienza Elena, Nasser Fadi, Kohl Susanne, Wissinger Bernd
Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Elfriede-Aulhorn 7, D-72076, Tuebingen, Germany.
BMC Med Genet. 2018 Jun 26;19(1):107. doi: 10.1186/s12881-018-0623-8.
Blue Cone Monochromacy (BCM) is a rare congenital cone dysfunction disorder with X-linked recessive mode of inheritance. BCM is caused by mutations at the OPN1LW/MW cone opsin gene cluster including deletions of the locus control region (LCR) and/or parts of the gene cluster. We aimed at investigating the clinical presentation, genetic cause and inheritance underlying a sporadic case of BCM.
We report a 24-year-old male presenting with congenital photophobia, nystagmus and colour vision abnormalities. There was no history of retinal dystrophy in the family. Clinical diagnosis of BCM was supported by genetic investigations of the patient and his family members. Molecular genetic analysis of the OPN1LW/OPN1MW gene cluster revealed a novel deletion of about 73 kb in the patient encompassing the LCR. The deletion was absent in the X-chromosomes of both the mother and transmitting grandfather.
The present report provides the clinical findings and the genetic basis underlying a sporadic BCM case which is caused by a de novo deletion within the OPN1LW/MW gene cluster originating from the mother's germline due to Alu-repeat mediated recombination. This is the first report of a de novo deletion resulting in BCM, highlighting the importance to consider BCM and perform genetic testing for this condition in male patients with cone dysfunction also in the absence of a positive family history.
蓝锥单色视(BCM)是一种罕见的先天性视锥细胞功能障碍疾病,呈X连锁隐性遗传模式。BCM由视蛋白基因簇OPN1LW/MW处的突变引起,包括基因座控制区(LCR)缺失和/或基因簇的部分区域缺失。我们旨在研究一例散发性BCM病例的临床表现、遗传病因及遗传方式。
我们报告一名24岁男性,有先天性畏光、眼球震颤和色觉异常。家族中无视网膜营养不良病史。对患者及其家庭成员的基因检测支持BCM的临床诊断。对OPN1LW/OPN1MW基因簇的分子遗传学分析显示,患者存在一个约73 kb的新缺失,该缺失包含LCR。母亲和传递致病基因的外祖父的X染色体中均未发现该缺失。
本报告提供了一例散发性BCM病例的临床发现和遗传基础,该病例由母亲生殖系中OPN1LW/MW基因簇内的从头缺失引起,是由Alu重复序列介导的重组所致。这是首例因从头缺失导致BCM的报告,强调了在男性视锥细胞功能障碍患者中,即使没有阳性家族史,也应考虑BCM并进行相关基因检测的重要性。